Founder and Owner, Ilesol Pharmaceuticals
Sasha Bajilo is the founder and owner of Ilesol Pharmaceuticals, a leading European producer of cannabinoid ingredients and formulations. Under Sasha’s leadership, Ilesol has grown into a trusted supplier for international wellness and pharmaceutical markets, recognised for its commitment to quality, research, and regulatory compliance.
Sasha brings hands-on industry expertise in large-scale cannabinoid extraction, product development, and navigating complex regulatory frameworks. His strategic insight and entrepreneurial approach strengthen the CTA’s efforts to build a transparent, responsible, and innovative cannabis and hemp sector in the UK and beyond.
Sasha is passionate about advancing industry standards, fostering cross-border partnerships, and ensuring that businesses of all sizes can thrive in a well-regulated environment. His work continues to influence the development of safe, effective, and sustainable cannabinoid products globally.
